• PIN14 Health and Economic IMPACT of 15-Valent Pneumococcal Conjugate Vaccine (V114) Serotypes in Adults 65 YEARS and Older in Korea

    Sep 1, 2020, 00:00

  • PIN53 The Usability Testing of the Integrated E-Healthcare Services (IEHS) Web-Based Application in the Therapy Management of HIV and Tuberculosis in Indonesia

    Sep 1, 2020, 00:00

  • PMH4 The Psychological and Behavioral Responses to Covid-19 Epidemic in Pregnant Women in China: A Nationwide Survey

    Sep 1, 2020, 00:00

  • PCN104 Treatment Patterns and Health Resource Utilization in Patients with HR+/HER2- Locally Advanced or Metastatic Breast Cancer in Real World Setting in Taiwan

    Sep 1, 2020, 00:00

  • PNS2 Voice Technology - an Opportunity to Broaden Participation in Patient Reported Outcomes Research

    Sep 1, 2020, 00:00

  • PND13 Burden of Illness of Spinal Muscular Atrophy: An Update

    Sep 1, 2020, 00:00

  • PIN37 Projection of Covid-19 Based on Decision Tree Analysis: WE Have NOT Won but WE Have NOT Lost the WAR!

    Sep 1, 2020, 00:00

  • PSY2 Evaluating Patient-Reported Outcomes and Work Productivity Among Patients with Psoriasis in Taiwan

    Sep 1, 2020, 00:00

  • PDB29 Diagnostic and Prognostic VALUE of Galectin-3 and GDF-15 in Diabetic Nephropathy Patients

    Sep 1, 2020, 00:00

  • PCN76 Analysis of the Status of the MULTI-Indications for Anticancer Drugs and Their Price Reduction in South Korea

    Sep 1, 2020, 00:00

  • PCV1 Cardiac Rehabilitation Program in a Tertiary Hospital in Peninsular Malaysia: Outcome and Associations

    Sep 1, 2020, 00:00

  • PNS23 Setting Health Priorities in Low-Income and Middle-Income Countries in the ASIA-Pacific Region: The Case of Papua New Guinea

    Sep 1, 2020, 00:00

  • PIH12 COMPARISON OF THE POST-MARKET UTILIZATION PATTERNS OF ALZHEIMER'S DISEASE TREATMENTS BETWEEN SOUTH KOREA AND AUSTRALIA: TIME TO CONSIDER REASSESSMENT OF COST-EFFECTIVENESS

    Sep 1, 2020, 00:00

  • PCN59 A Systematic Review of Prognostic Factor That IMPACT on Overall Survival and Proression-Free Survival in Triple-Negative Breast Cancer (TNBC)

    Sep 1, 2020, 00:00

  • PCV13 Health Economic Evaluation of Screening and Treating Children with Familial Hypercholesterolemia EARLY in Life: Many Happy Returns on Investment?

    Sep 1, 2020, 00:00

  • PAM4 Cost-Effectiveness of Dangguixu-SAN for Patients with Mild to Moderate Ankle Sprain

    Sep 1, 2020, 00:00

  • Knowledge and Attitude of Physicians Towards the Cost of Commonly Prescribed Medicines: A Case Study in Three Nigerian Healthcare Facilities

    Sep 1, 2020, 00:00

  • PMD1 Effectiveness and Cost Analysis for Peripheral Inserted Central Catheter VS Central Venous Catheter in China

    Sep 1, 2020, 00:00

  • Cefuroxime (Aprokam®) in the Prophylaxis of Postoperative Endophthalmitis After Cataract Surgery Versus Absence of Antibiotic Prophylaxis: A Cost-Effectiveness Analysis in Poland

    Sep 1, 2020, 00:00

  • PCN28 Cost-Effectiveness Analysis of Avelumab for Treatment-Experienced and Treatment-Naïve Patients with Metastatic Merkel CELL Carcinoma in Taiwan

    Sep 1, 2020, 00:00

  • PNS63 A Cross-Sectional Study About Medications Wastage In Saudi Arabia

    Sep 1, 2020, 00:00

  • PMD11 Efficacy of Stereotactic Body Radiotherapy for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis

    Sep 1, 2020, 00:00

  • PMS7 Osteoporosis Diagnosis and Treatment Among Women in China: A Simulation Projection Model of Clinical and Economic Benefits through 2040

    Sep 1, 2020, 00:00

  • PGI8 Facility Size-Based Diagnostic Patterns of the Crohn's Disease-Associated Perianal Fistula Using an Employer-Based Health Insurance Claims Database in JAPAN

    Sep 1, 2020, 00:00

  • PMH9 Comparison of Approved Doses of Lemborexant for Insomnia in Placebo-Controlled Trials: A Systematic Review and Network Meta-Analysis

    Sep 1, 2020, 00:00

  • PMU21 Incorporating Preference Heterogeneity in Public Healthcare Policy Decision-Making: A Scoping Review of the Literature

    Sep 1, 2020, 00:00

  • PRO17 Healthcare Resource Utilization (HCRU) in Patients with Palmoplantar Pustulosis (PPP) in JAPAN: A Claims Database Study

    Sep 1, 2020, 00:00

  • PNS15 Effects of Different Family Planning Policies on Cesarean Section Rates from 2009 to 2019: A Population-Based Registry in China

    Sep 1, 2020, 00:00

  • The Cost-Effectiveness of Abdominal Aortic Aneurysm Screening in Estonia

    Sep 1, 2020, 00:00

  • PDG16 Pharmaceutical Expenditure Monitoring for Price-Volume Negotiation in South Korea : Lessons and Improvement Points Learned over 11 YEARS

    Sep 1, 2020, 00:00

  • PCN91 Penetration of Artificial Intelligence (AI) and Machine Learning (ML) in the Randomized Controlled Setting of Oncology

    Sep 1, 2020, 00:00

  • PGI6 DISEASE BURDEN OF MODERATE TO SEVERE CROHN'S DISEASE UNDER CURRENT TREATMENT PATTERN IN CHINA

    Sep 1, 2020, 00:00

  • PDB23 Efficacy and Safety of Teprotumumab in the Treatment of Thyroid Eye Disorder: A Systematic Review and Meta-Analysis

    Sep 1, 2020, 00:00

  • PND6 Drug Utilization of Gastrodin Injection on the Treatment of Dizziness and Vertigo: An Analysis Using Electronic Medical Records in China

    Sep 1, 2020, 00:00

  • PIN13 Clinicoeconomic IMPACT of an Alcohol Based Hand RUB to Reduce Gram Negative MULTI Drug Resistant Bacteria: A Simulation Study in an Indian Healthcare Setting

    Sep 1, 2020, 00:00

  • PNS9 The Potential IMPACT of External Reference Pricing Rules on Selected Drug Prices in China

    Sep 1, 2020, 00:00

  • PCN72 APAC Overview of the Accelerated Approval Pathways: Applications in LUNG Cancer

    Sep 1, 2020, 00:00

  • PRO3 Psoriasis As a PROXY for Health-Related Utility Values for Erythrodermic Cutaneous T-CELL Lymphoma

    Sep 1, 2020, 00:00

  • PIH2 Does Fertility Treatment Provide Good VALUE for Money? a Cost-Benefit Analysis

    Sep 1, 2020, 00:00

  • PRS14 The IMPACT of Heart Failure on the Economic Burden of Various Phenotypes of Bronchial Obstructive Diseases

    Sep 1, 2020, 00:00

  • PDB30 Digital Medication Health Service Platforms of Pharmaceutical Companies for Type 2 Diabetes Mellitus (T2DM) Patients: A Content Analysis of Application

    Sep 1, 2020, 00:00

  • PNS16 Health and Economic Burden of Smoking in Indonesia

    Sep 1, 2020, 00:00

  • PMD4 Analysis of Costs, Length of Hospital STAY (LOS), Readmission and Quality of Life in Patients Undergoing Primary TOTAL Knee Arthroplasty (TKA) from China ATTUNE® Study

    Sep 1, 2020, 00:00

  • PCN45 Disease Burden of Breast Cancer UNDER the Current Treatment Pattern in China

    Sep 1, 2020, 00:00

  • PDB5 Assesment the Quality of Life in Children with Type 1 Diabetes

    Sep 1, 2020, 00:00

  • Financial Disclosure Information

    Sep 1, 2020, 00:00

  • PND24 Target Identification and Drug Repurposing for Parkinson's Disease: A NOVEL Integrative Computational Approach

    Sep 1, 2020, 00:00

  • PMU6 Evaluation of the Application of the Hospital Management Program for Prevention and Treatment of Venous Thrombosis Based on Information Technology

    Sep 1, 2020, 00:00

  • PCV16 Increasing Burden of Cardiovascular Disease (CVD), the Associated Risk Factors and Drug Utilization Among Smokers in the US: A Study Based on Nhanes from 2005 to 2016

    Sep 1, 2020, 00:00

  • PCN9 Bayesian Network Meta-Analyses of the Efficacy of LONG-Acting Release Somatostatin Analogs in Patients with Advanced Neuroendocrine Tumors: Application of Different Parametric and Fractional Polynomial Methods

    Sep 1, 2020, 00:00

  • PDG5 Cost- Effectiveness Analysis between Aprepitant and Fosaprepitant in the Prevention of Chemotherapy-Induced Nausea and Vomiting in China

    Sep 1, 2020, 00:00

  • PMU18 Budget IMPACT Analysis of the Eluvia Drug-Eluting Stent for Peripheral Artery Disease in Korea

    Sep 1, 2020, 00:00

  • PCN64 Frequency of ORAL Mucositis in Male Patients Receiving Cancer Therapy

    Sep 1, 2020, 00:00

  • PMD3 A Budget IMPACT Analysis of Implementing Safety Needles for Venous Blood Collection in China

    Sep 1, 2020, 00:00

  • PIN3 Is Dolutegravir Cost Effective in Treating Patients Living with HIV?

    Sep 1, 2020, 00:00

  • PGI1 Systematic Review and Network Meta-Analysis of Infliximab, Adalimumab, Golimumab, Vedolizumab, Andtofacitinib for Moderate-to-Severe Ulcerative Colitis in ANTI-TNF-ALPHA-Naive Patients

    Sep 1, 2020, 00:00

  • PCV17 Systematic Literature Review of Cardiovascular Risk Factor Management in 11 Asian Markets

    Sep 1, 2020, 00:00

  • PCN67 Time to Onset Analysis of Sildenafil Associated Malignant Melanoma Using DATA from FDA Adverse Event Reporting System (FAERS) Database

    Sep 1, 2020, 00:00

  • PNS48 The Analysis of Sources of Utility Values USED in Cost-Utility Analyses in China

    Sep 1, 2020, 00:00

  • PDB24 Characteristics and Treatment Patterns of ANTI-VEGF Use Among Patients with Diabetic Macular Edema in Taiwan: Real-World DATA from Population-Based Health Claims

    Sep 1, 2020, 00:00

  • PCN61 Frequency of Myalgia in Patients with Gynecological Cancer

    Sep 1, 2020, 00:00

  • PCV10 A MODEL-Based Cost-Effectiveness Analysis of Pharmacogenomic Panel Testing in Cardiovascular Disease Management: Preemptive, Reactive or NONE?

    Sep 1, 2020, 00:00

  • PIN36 Comparison of Vaccine Market Access Pathways in European and Asian Countries

    Sep 1, 2020, 00:00

  • PIN2 Heterogeneity in Association of Use of Direct Acting Antivirals with Mortality Among Patients with Hepatitis C in the United States

    Sep 1, 2020, 00:00

  • PCN22 Cost-Effectiveness of Pembrolizumab PLUS Axitinib Versus Nivolumab PLUS Ipilimumab As First-LINE Treatment of Advanced Renal CELL Carcinoma

    Sep 1, 2020, 00:00

  • PNS4 CAN Entry-Agreements be Managed?

    Sep 1, 2020, 00:00

  • PMD2 The Relationship between Sedatives and Risk of Ventilator-Associated Events

    Sep 1, 2020, 00:00

  • PCN90 Development of Time-Dependent Markov MODEL to Evaluate the Cost-Effectiveness of Treatment Options for Relapsed or Refractory Peripheral T-CELL Lymphoma in South Korea

    Sep 1, 2020, 00:00

  • PCN81 The Role of Different Specialties in the Management of NON-SMALL CELL LUNG Cancer: Insights from a Real-World Study

    Sep 1, 2020, 00:00

  • PMH16 Computer GAME Addiction CAN Cause the Delay in Development of Visuospatial Abilities in Children

    Sep 1, 2020, 00:00

  • PCN46 Disease Burden of Chronic Lymphocytic Leukemia/SMALL Lymphocytic Lymphomaunder Current Treatment Pattern in China

    Sep 1, 2020, 00:00

  • PIN55 TREND in Medical Utilization and Treatment Status of CHB-Treated Patients in South Korea

    Sep 1, 2020, 00:00

  • PCV27 Assessment of Health Related Quality of Life Among Adherent and NON-Adherent Medication Group of Coronary Artery Disease Patients

    Sep 1, 2020, 00:00

  • PMH14 Uncovering the Hidden Burden of Depression: A Country Comparison

    Sep 1, 2020, 00:00

  • PUK1 Low-Flux Hemodialysis Versus High-Flux Hemodialysis for END-STAGE Kidney Disease Meta Analysis

    Sep 1, 2020, 00:00

  • PIT2 Descriptive Analysis of Complications, Length of STAY (LOS) and Costs of Surgical Fixation for Femoral Neck Fracture (FNF) in JAPAN

    Sep 1, 2020, 00:00

  • PGI4 Projecting the Health Impact of Vaccination with Rotateq in China

    Sep 1, 2020, 00:00

  • PCV12 Radiofrequency Catheter Ablation Using Thermocool Smarttouch with or without Ablation INDEX (AI) Guided Versus the 2ND-Generation Cryoballoon for the Treatment of Atrial Fibrillation in China: A Cost- Effectiveness Analysis

    Sep 1, 2020, 00:00

  • PCN79 Willingness to Pay for Cancer Screening Testing in Malaysia

    Sep 1, 2020, 00:00

  • PCN32 Cost Analysis of Chronic Myeloid Leukemia Patients Using Tyrosine Kinase Inhibitor in Vietnam

    Sep 1, 2020, 00:00

  • PBI5 Future Trends on the Biosimilar Uptake in China, JAPAN, the US, the EU4 and the UK

    Sep 1, 2020, 00:00

  • PRO6 Epidemiology and Treatment Patterns of Hemophilia a in Taiwan from 2013 to 2017

    Sep 1, 2020, 00:00

  • PIN12 Health and Economic IMPACT of 15-Valent Pneumococcal Conjugate Vaccine (V114) Serotypes in Adults 70 YEARS and Older in Australia

    Sep 1, 2020, 00:00

  • PIH17 Efficacy, Tolerability And Medication Adherence Of Twice-Daily Dosing Schedule Of Deferasirox In Transfusion-Dependent Paediatric Beta-Thalassemia Patients: A Randomized Controlled Study

    Sep 1, 2020, 00:00

  • PND2 A Meta-Analysis of Efficacy and Safety of Vesicular Monoamine Transporter Type 2 Inhibitors for Treatment of Huntington Chorea

    Sep 1, 2020, 00:00

  • PIN54 Association of Maternal Hbsag and Hbeag Serostatus and Congenital Abnormalities Following Assisted Reproduction: A Population-Based Study

    Sep 1, 2020, 00:00

  • PAM6 Cost IMPACT Analysis for Coated VS NON-Coated CVC in China

    Sep 1, 2020, 00:00

  • PMU27 Comorbid Depression: IMPACT on Costs in Patients with EARLY Rheumatoid Arthritis

    Sep 1, 2020, 00:00

  • PND22 Application of Therapeutic Plasma Exchange in a Single Public Hospital

    Sep 1, 2020, 00:00

  • PDB17 Time to Onset Analysis of Ipilimumab Associated Hypophysitis Using DATA from FDA Adverse Event Reporting System (FAERS) Database

    Sep 1, 2020, 00:00

  • PIN28 Prediction of the PEAK Dates of the Numbers of COVID19 Pandemic Patients

    Sep 1, 2020, 00:00

  • PIN9 Overview of Systematic Reviews of Economic Evaluations of Human Papillomavirus Vaccines

    Sep 1, 2020, 00:00

  • PRO10 Income LEVEL Shift of RARE Disease Patients in South Korea

    Sep 1, 2020, 00:00

  • PDB25 Long-Term Drug Survival and Low Remission Rates in Dyslipidemia Patients Having Drug Safety Concerned and Safety Literacy

    Sep 1, 2020, 00:00

  • PIN6 Rational Antibiotic Use in Outpatients with UPPER Respiratory TRACT Infections at District Health Promotion Hospital Panasnikom Chonburi

    Sep 1, 2020, 00:00

  • Donor Human Milk for Preterm Infants: A Cost-Consequence Analysis of Alternative Preservation Methods

    Sep 1, 2020, 00:00

  • PSU11 Trends in the Adoption of Minimally Invasive Partial Nephrectomy in South Korea

    Sep 1, 2020, 00:00

  • PND19 Economic and Social Factors Affecting Healthcare Expenditure for Households with Cerebrovascular Diseases

    Sep 1, 2020, 00:00

  • Idiopathic Pulmonary Fibrosis: Utilization of Health Services and Out-Of-Pocket Health Expenditures in Greece

    Sep 1, 2020, 00:00

  • PNS35 Health Service Utilization of Adults with Supplemental Private Health Insurance in South Korea: 2014-2016

    Sep 1, 2020, 00:00

  • PCN93 A Comparison of Machine Learning (ML) Algorithms Performance Against Medical Professionals in Diagnosing LUNG Cancer: A Targeted Review and Meta-Analysis

    Sep 1, 2020, 00:00

  • PIN18 Health and Economic Burden Associated with 15-Valent Pneumococcal Conjugate Vaccine (V114) Serotypes in Children in New Zealand

    Sep 1, 2020, 00:00

  • PMS3 Calibration of a Cost-Effectiveness MODEL for Systemic LUPUS Erythematosus Using NEWLY Observed LONG-TERM Organ Damage DATA

    Sep 1, 2020, 00:00

  • PCN97 Comparison of Disease-Specific (QLU-C10D) and Generic (EQ-5D) Utilities in Cost-Effectiveness Analysis

    Sep 1, 2020, 00:00

  • PCN105 Investigating Medical Utilization in Ductal Carcinoma in Situ (DCIS) Women: A Real-World Data Analysis

    Sep 1, 2020, 00:00

  • PND14 Identifying Patients with RARE Refractory Epilepsies in Japanese Health Databases: Feasibility for a Burden of Illness Study

    Sep 1, 2020, 00:00

  • PCN85 Comparison of Observed LONG-TERM Overall Survival with Extrapolated Overall Survival for Pembrolizumab Monotherapy Assessed By Australian Reimbursement Authorities

    Sep 1, 2020, 00:00

  • PRO4 Lanreotide Acetate Injection for the Treatment of Acromegaly: A Budget IMPACT Analysis

    Sep 1, 2020, 00:00

  • PMH7 Depression and Insomnia at Burapha University, Thailand 2019

    Sep 1, 2020, 00:00

  • PMS17 Usability Testing of a Patient Engagement Digital Platform for TOTAL Knee Arthroplasty (TKA) Patients in JAPAN

    Sep 1, 2020, 00:00

  • PNS73 Retrospective Study for Comorbidities in ACTIVE Population Using Japanese Health Insurance Claims Database

    Sep 1, 2020, 00:00

  • PND8 Economic Evaluation of Clinical Pathways Management for Cerebral Infarction in RURAL Area of China

    Sep 1, 2020, 00:00

  • PRS5 An Environment IMPACT Analysis of the Use of Respimat RE-Usable for the Treatment of Chronic-Obstructive Pulmonary Disorder (COPD) in South-EAST ASIA and South Korea

    Sep 1, 2020, 00:00

  • PNS31 Increased Cigarette Taxes and Quitting Behavior Among Adults

    Sep 1, 2020, 00:00

  • A Contingent Valuation Study for Eliciting a Monetary Value of a Quality-Adjusted Life-Year in the General Greek Population [Editor's Choice]

    Sep 1, 2020, 00:00

  • PCV22 An Investigation of Health Technology Assessments (HTAS) on Transcatheter Aortic Valve Implantation (TAVI) over Time: As Evidence Evolves How Does HTA Respond?

    Sep 1, 2020, 00:00

  • PNS13 Assessment of Satisfaction with New Competencies and Roles of Nurses in the Framework of Nursing Reform in Kazakhstan

    Sep 1, 2020, 00:00

  • PDB12 Short-TERM Cost-Effectiveness of Insulin Degludec/Insulin Aspart Versus Biphasic Insulin Aspart 30 in Patients with Type 2 Diabetes in China

    Sep 1, 2020, 00:00

  • PSU13 The Cost-Effectiveness of I-Factor Compared to Local Autograft in Anterior Cervical Discectomy and Fusion Surgery

    Sep 1, 2020, 00:00

  • PNS8 An Analysis of Utility Values USED in Cost Utility Studies Conducted from an Indian Perspective

    Sep 1, 2020, 00:00

  • PNS68 Valuating the CHILD Health Utility 9-Dimention in JAPAN: Results from a Nation-Wide School-Based Survey

    Sep 1, 2020, 00:00

  • PNS64 Landscape Analysis of Studies in Asia Eliciting Patient Preferences for Therapeutic Interventions

    Sep 1, 2020, 00:00

  • PRO2 Economic Evaluation of Reproductive Carrier Screening for Recessive Genetic Conditions: A Systematic Review

    Sep 1, 2020, 00:00

  • PMS13 Incorporating Patient Preferences in Health Technology Assessment – Is Individual Simulation Modelling Useful?

    Sep 1, 2020, 00:00

  • PBI4 The ISSUE of Patient CO-Pay and Biosimilars in JPN: Is IT Really an ISSUE?

    Sep 1, 2020, 00:00

  • PMD8 Mortality after Use of paclitaxel-Based Devices in Peripheral Arteries : A Real-World Analysis

    Sep 1, 2020, 00:00

  • PRO7 Economic Burden of Pompe Disease in China: Empirical Evidences and Simulation of Policy Effects

    Sep 1, 2020, 00:00

  • PMU16 Assessing Health Technologies in EARLY Detection of Primary Immunodeficiency Diseases: A Case Study of Evidence-Based VALUE Framework in RARE Diseases

    Sep 1, 2020, 00:00

  • PMU7 Drug-Drug Interaction ( DDI ) Pharmacoeconomic Studies of Waste. Experience of a Single Institution Based on Rwd at a Private Health Insurance in LATAM

    Sep 1, 2020, 00:00

  • PRO9 Orphan Drug Pricing in JAPAN Since Reform

    Sep 1, 2020, 00:00

  • PCN89 Constructing Comparator Survival DATA: Simulated Versus Individual Patient DATA

    Sep 1, 2020, 00:00

  • PMS9 Expected Benefits over the Next 20 Years of Osteoporotic Secondary Fracture Prevention Policies Amongst Women in Thailand

    Sep 1, 2020, 00:00

  • PIN20 Study on Disease Treatment Preference and Willingness Payment in Hepatitis C Patients

    Sep 1, 2020, 00:00

  • PCN14 Disease Burden of Waldenstrom's Macroglobulinemia UNDER the Current Treatment Pattern in China

    Sep 1, 2020, 00:00

  • PCN68 Real-World Cardiac Safety of Systemic Therapies for HER2+ Metastatic Breast Cancer in Older Versus Younger Patients: A Retrospective Cohort Study Using Electronic Health Record DATA and Cancer Registries

    Sep 1, 2020, 00:00

  • PNS28 Recent Japanese Generic Drug Policy and Future Directions

    Sep 1, 2020, 00:00

  • PDB19 Estimating National Burden of Disease Due to Type 2 Diabetes Considering Complications in Korea

    Sep 1, 2020, 00:00

  • PMU24 Using the Medication Adherence Reasons Scale (MAR-SCALE) to Identify the Reasons for Medication NON-Adherence Among Type 2 Diabetes, Migraine, and Depression Medication Users in JAPAN

    Sep 1, 2020, 00:00

  • PCV26 Quality of Life Improves More for People Who Receive Proactive Absolute Cardiac Risk Management in a Rapid Access Chest Pain Clinic Compared to Usual Care

    Sep 1, 2020, 00:00

  • PNS43 Economic Evaluation of a Community-Based Maternal and CHILD Health Service in JAPAN

    Sep 1, 2020, 00:00

  • PRO16 Healthcare Resource Utilization (HCRU) in Patients with Generalized Pustular Psoriasis (GPP) in JAPAN: A Claims Database Study

    Sep 1, 2020, 00:00

  • PCN35 Out-of-Pocket Cost of Cancer Treatement: A Systematic Review for Literatures from Taiwan

    Sep 1, 2020, 00:00

  • PMU15 Utilization and Spending of Low-VALUE Healthcare UNDER a National Health Insurance Program: A Nationwide Population-Based Study

    Sep 1, 2020, 00:00

  • PRO1 The Market Access Landscape for Orphan Drugs in APAC: A Comparison of Policies in FIVE Major Markets

    Sep 1, 2020, 00:00

  • PIH3 Pharmacoeconomic Evaluation of ORAL Ibuprofen Versus Intravenous Ibuprofen in Preterm Infants with Patent Ductus Arteriosus in the Neonatal Intensive Care Units in Qatar

    Sep 1, 2020, 00:00

  • PMH11 Post Partum Depression:Prevalence, Risk Factors/Causes, Knowledge and Medication Use

    Sep 1, 2020, 00:00

  • PUK3 Cost Consequence Analysis of Remote Monitoring with the Homechoice Claria® with Sharesource® Platform for Automated Peritoneal Dialysis Patients in the Australian Setting

    Sep 1, 2020, 00:00

  • PIH4 Preoperative Skin Preparation for Caesarean Deliveries in Australian Public Hospitals: Surgical Site Infecton and Cost Outcomes Associated with Using Alcoholic Chlorhexidine Gluconate Applicator Versus Bulk Aqueous Povidone Iodine Solu ...

    Sep 1, 2020, 00:00

  • PCN11 The Challenges and Unmet Needs in the Management of Hepatocellular Carcinoma (HCC) Patients and Burden of Advanced HCC across Hong Kong, Singapore and Thailand

    Sep 1, 2020, 00:00

  • PRS2 Impact Of Knowledge And Attitude On Antibiotic Used For Upperrespiratory Tract Infections At Burapha University 2019

    Sep 1, 2020, 00:00

  • PCN56 Addressing the Credibility GAP of Real-World Evidence Generation in Southeast ASIA: An Analysis of 200 Articles over 10 YEARS

    Sep 1, 2020, 00:00

  • PDB1 Telemedicine Use for Gestational Diabetes: A Systematic Review and Meta-Analysis of Randomised Controlled Trials

    Sep 1, 2020, 00:00

  • PMD13 Estimating the Cost of Treating Myasthenia Gravis Patient in a Single Public Hospital

    Sep 1, 2020, 00:00

  • PUK6 Assessing Trend In Medical Expenditure And Measuring The Impact Of Health-Related Quality Of Life (HRQOL) On Medical Expenditure For U.S. Adults With Diabetes Associated Chronic Kidney Disease (CKD)Using 2002-2016 Medical Expenditure P ...

    Sep 1, 2020, 00:00

  • PIN4 Associations between Thromboprophylaxis and Ventilator-Associated Events Among Patients Receiving Mechanically Ventilated

    Sep 1, 2020, 00:00

  • PCV5 Cost-Effectiveness Analysis of Apixaban in Treatment of Atrial Fibrillation: A Systematic Review

    Sep 1, 2020, 00:00

  • PDB26 Knowledge, Attitude and Practices of Insulin Self-Administration Techniques Among Diabetic Patients

    Sep 1, 2020, 00:00

  • PDB14 Cost-Effectiveness of Liraglutide Versus Exenatide, BOTH in Combination with Metformin for Patients with Type 2 Diabetes in China

    Sep 1, 2020, 00:00

  • PMS8 Estimating the Future Clinical and Economic Benefits of Improving Osteoporosis Diagnosis and Treatment Rates Among Women in South Korea: A Simulation Projection Model from 2020-2040

    Sep 1, 2020, 00:00

  • PDG18 Availability, Cost and Affordability of Selected Antibiotics and Antiviral Medicines Against Infectious Diseases from 2013 to 2019 in Nanjing, China

    Sep 1, 2020, 00:00

  • PIN16 Disease Burden of Progressive Chronic Hepatitis B in China

    Sep 1, 2020, 00:00

  • PSS3 Bioinformatics Analysis of Potential Targets for Drug Repurposing in Contact Eczema through Microarray Profiles

    Sep 1, 2020, 00:00

  • PDG1 Prevalence and Determinants of Serious Spontaneously Reported Adverse Drug Events Among Three Outpatient Care Settings in Ghana: Findings and Implications

    Sep 1, 2020, 00:00

  • PNS51 The Role of Patients in Health Technology Assessment Process - Experience of Taiwan

    Sep 1, 2020, 00:00

  • PCN27 Study of Initial Treatment Cost for ACUTE Leukemia Patients in Vietnam

    Sep 1, 2020, 00:00

  • PNS32 Impoverishing Effects Of Out-Of-Pocket Health Expenditures In India

    Sep 1, 2020, 00:00

  • PNS5 Comparison of Instruments Valuing Health-Related Productivity Losses

    Sep 1, 2020, 00:00

  • PIN5 Evaluating Treatments and Corresponding Mortality Rates in Patients with Acinetobacter Baumannii Infections

    Sep 1, 2020, 00:00

  • PRO18 Incidence, Mortality, Hospitalizations, and Expenditures for Pemphigus in Taiwan

    Sep 1, 2020, 00:00

  • PMH12 Trends in Use of Prescription, over the Counter, and Traditional Chinese Medicine for Mental Health Conditions in China, 2009 - 2017

    Sep 1, 2020, 00:00

  • PCN75 Characterization of Oncology Managed Entry Agreements (MEA) in APAC and Assessment of Payer Considerations

    Sep 1, 2020, 00:00

  • PCN71 Comparing the International Price of Anticancer Drugs and Improving Their Accessibility in South Korea

    Sep 1, 2020, 00:00

  • PNS59 Reliability and Validity of the SF-12V2 Health-Related Quality of Life Survey and Disutilities Associated with Relevant Conditions in the U.S. Older Adult Population

    Sep 1, 2020, 00:00

  • PCN47 Disease Burden of Gastric Cancer UNDER the Current Treatment Pattern in China

    Sep 1, 2020, 00:00

  • PIN21 Cost-Effectiveness of Ceftazidime-Avibactam for Gram-Negative Infections with Limited Treatment Options in China

    Sep 1, 2020, 00:00

  • PCN4 Aromatase Inhibitors and Bisphosphonate Use in Postmenopausal Women with Hormone-Receptor Positive Breast Cancer in Hong Kong

    Sep 1, 2020, 00:00

  • Assessing Patient Knowledge of Asthma Using a Newly Validated Tool

    Sep 1, 2020, 00:00

  • PDG8 The Cost-Effectiveness of Direct-Acting Antivirals Coverage Policies for Patients with Hepatitis C VIRUS Infection in Taiwan

    Sep 1, 2020, 00:00

  • PCN42 A Real World Comparison of Utility Values Derived from a Discrete Choice Experiment Versus Patient Reported Outcomes in Clinical Trials

    Sep 1, 2020, 00:00

  • PNS10 Economic Evaluation in the Philippines before the Era of Mandatory Health Technology Assessment: A Systematic Review

    Sep 1, 2020, 00:00

  • PMU29 Real World DATA Availability and Quality in ASIA Pacific. Assessment and Implications for Research and Healthcare Decision-Making

    Sep 1, 2020, 00:00

  • PCN51 Disease Burden of Mantle CELL Lymphoma UNDER Current Treatment Pattern in China

    Sep 1, 2020, 00:00

  • PIH16 Use of Tripod Checklist to Evaluate the Reporting Quality of Prognostic Prediction Models for Obstetric Care

    Sep 1, 2020, 00:00

  • PNS24 Willingness-to-Pay Thresholds Applied for Health Economic Analyses in Oncology in China: A Targeted Literature Review

    Sep 1, 2020, 00:00

  • PIN44 Benefit Design Considerations during Emergencies: Lessons from Covid 19

    Sep 1, 2020, 00:00

  • PDB16 Identifying Prevalence and Risk Factors of Poor Glycemic Control Among Diabetic Patients in a Central RURAL Province of Saudi Arabia

    Sep 1, 2020, 00:00

  • PND27 Valuing Health States Using Discrete Choice Experiment: Case of Cerebral Palsy

    Sep 1, 2020, 00:00

  • PDG25 Drug Therapy Problem and Contributing Factors in Ethiopia: A Systematic Review and Meta-Analysis

    Sep 1, 2020, 00:00

  • PCN6 Thromboembolic Events Among Cancer Patients Treated with Chemotherapy at Adult Oncology Unit of Tikur Anbessa Specialized Hospital: A Retrospective CROSS-Sectional Study

    Sep 1, 2020, 00:00

  • PCV29 Iqvia Hospital Information System DATA Secondary Use for Outcome Identification to Assess the Validity of Definitions

    Sep 1, 2020, 00:00

  • PNS56 Effect of the Recall Period for Estimating Inpatient out-of-Pocket Expenditures: Validation Study in Vietnam

    Sep 1, 2020, 00:00

  • PBI3 The Economic Evaluation Of Clopidogrel In Antiplatelet Therapy Guided By CYP2C19 Gene Polymorphism In The Treatment Of Patients With Coronary Heart Disease

    Sep 1, 2020, 00:00

  • PSU4 Cost Comparison and Budget IMPACT MODEL for Radical Prostatectomy in England

    Sep 1, 2020, 00:00

  • PSS5 Disease Burden of Rvo-ME in China——a Societal VALUE Perspective

    Sep 1, 2020, 00:00

  • PNS67 The Humanistic Burden of Caregiving in China, Japan, and the US

    Sep 1, 2020, 00:00

  • PUK5 Remaining Waitlisted for a Superior Quality Kidney; An Economic Evaluation of Contemporary Transplant Practice

    Sep 1, 2020, 00:00

  • PMS11 Pharmaco-Economic Study of Intra-Artcular Hyaloronic Acid VS Intra- Articular Corticosteroid in Egyptian Patients Receiving Standard Care Therapy from the Patient Perspective

    Sep 1, 2020, 00:00

  • PCN84 Comparison of Treatment Among Peripheral T-CELL Lymphoma and Cutaneous T-CELL Lymphoma in China and United States: Results of Primary Market Research Survey of Oncologists

    Sep 1, 2020, 00:00

  • PCN62 Investigation of Diseases Incidence after Administration of Immune Check Inhibitors in LUNG Cancer Based on Claims DATA in JAPAN

    Sep 1, 2020, 00:00

  • PCN39 Cost-Effectiveness of Brentuximab Vedotin for Relapsed or Refractory Systemic Anaplastic Large-CELL Lymphoma in China

    Sep 1, 2020, 00:00
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6 (current)
  • 7
  • 8
  • 9
  • 10
  • »